MEDIOS AG (ILM1.DE) Stock Price, Forecast & Analysis
Europe • Frankfurt Stock Exchange • FRA:ILM1 • DE000A1MMCC8
ILM1.DE Key Statistics, Chart & Performance
The current stock price of ILM1.DE is 16.44 EUR. In the past month the price increased by 6.76%. In the past year, price increased by 30.11%.
ILM1.DE Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to ILM1.DE. When comparing the yearly performance of all stocks, ILM1.DE is one of the better performing stocks in the market, outperforming 84.69% of all stocks.
ILM1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to ILM1.DE. While ILM1.DE seems to be doing ok healthwise, there are quite some concerns on its profitability.
ILM1.DE Financial Highlights
Over the last trailing twelve months ILM1.DE reported a non-GAAP Earnings per Share(EPS) of 0.87. The EPS increased by 63.63% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.09% | ||
| ROA | 2.34% | ||
| ROE | 4.25% | ||
| Debt/Equity | 0.32 |
ILM1.DE Forecast & Estimates
12 analysts have analysed ILM1.DE and the average price target is 24.48 EUR. This implies a price increase of 48.91% is expected in the next year compared to the current price of 16.44.
For the next year, analysts expect an EPS growth of 5.3% and a revenue growth 8.28% for ILM1.DE
ILM1.DE Ownership
ILM1.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AMP | AMPLIFON SPA | 18.54 | 3.138B | ||
| AXNA | AMPLIFON SPA | 18.87 | 3.082B | ||
| FAGR | FAGRON | 14.54 | 1.639B | ||
| UPR | UNIPHAR PLC | 15.83 | 1.046B | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 11.14 | 162.14M | ||
| VME | VIROMED MEDICAL AG | N/A |
Related stock screener links
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About ILM1.DE
Company Profile
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 999 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Company Info
MEDIOS AG
Heidestrasse 9
Berlin BERLIN DE
Employees: 712
Phone: 4930232566800
MEDIOS AG / ILM1.DE FAQ
What does ILM1 do?
Medios AG is a holding company, which engages in the provision of pharmaceutical drugs. The company is headquartered in Berlin, Berlin and currently employs 999 full-time employees. The firm covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. The company operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
What is the stock price of MEDIOS AG today?
The current stock price of ILM1.DE is 16.44 EUR. The price increased by 0.86% in the last trading session.
Does MEDIOS AG pay dividends?
ILM1.DE does not pay a dividend.
What is the ChartMill technical and fundamental rating of ILM1 stock?
ILM1.DE has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists ILM1 stock?
ILM1.DE stock is listed on the Frankfurt Stock Exchange exchange.
What is the analyst forecast for ILM1.DE stock?
12 analysts have analysed ILM1.DE and the average price target is 24.48 EUR. This implies a price increase of 48.91% is expected in the next year compared to the current price of 16.44.
Who owns MEDIOS AG?
You can find the ownership structure of MEDIOS AG (ILM1.DE) on the Ownership tab.